$47.30
0.330.70%
At Close: -
$47.30
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Varonis Systems
VRNSNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Varonis Systems (NASDAQ:VRNS) Stock, Analyst Ratings, Price Targets, Forecasts
Varonis Systems Inc has a consensus price target of $48.11 based on the ratings of 21 analysts. The high is $65 issued by Wedbush on February 6, 2024. The low is $26 issued by Jefferies on January 5, 2023. The 3 most-recent analyst ratings were released by Barclays, JP Morgan, and RBC Capital on July 11, 2024, June 14, 2024, and May 7, 2024, respectively. With an average price target of $55.67 between Barclays, JP Morgan, and RBC Capital, there's an implied 17.69% upside for Varonis Systems Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
JP Morgan
RBC Capital
Baird
Truist Securities
1calculated from analyst ratings
Analyst Ratings for Varonis Systems
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/11/2024 | Buy Now | 16.28% | Barclays | Saket Kalia | $53 → $55 | Maintains | Overweight | Get Alert |
| 06/14/2024 | Buy Now | 14.16% | JP Morgan | Brian Essex | $50 → $54 | Upgrade | Neutral → Overweight | Get Alert |
| 05/13/2024 | Buy Now | — | Needham | Alex Henderson | — | Reiterates | → Hold | Get Alert |
| 05/07/2024 | Buy Now | 22.62% | RBC Capital | Matthew Hedberg | $56 → $58 | Maintains | Outperform | Get Alert |
| 05/07/2024 | Buy Now | 5.71% | Baird | Shrenik Kothari | $48 → $50 | Maintains | Neutral | Get Alert |
| 03/15/2024 | Buy Now | 18.39% | RBC Capital | Matthew Hedberg | → $56 | Reiterates | Outperform → Outperform | Get Alert |
| 03/13/2024 | Buy Now | 16.28% | Truist Securities | Joel Fishbein | $50 → $55 | Reiterates | Buy → Buy | Get Alert |
| 02/06/2024 | Buy Now | 5.71% | JP Morgan | Brian Essex | $49 → $50 | Maintains | Neutral | Get Alert |
| 02/06/2024 | Buy Now | 1.48% | Baird | Shrenik Kothari | $45 → $48 | Maintains | Neutral | Get Alert |
| 02/06/2024 | Buy Now | 33.19% | JMP Securities | Erik Suppiger | → $63 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/06/2024 | Buy Now | 16.28% | Stephens & Co. | Brian Colley | → $55 | Reiterates | Overweight → Overweight | Get Alert |
| 02/06/2024 | Buy Now | -4.86% | Wells Fargo | Andrew Nowinski | $42 → $45 | Maintains | Equal-Weight | Get Alert |
| 02/06/2024 | Buy Now | 18.39% | RBC Capital | Matthew Hedberg | $52 → $56 | Maintains | Outperform | Get Alert |
| 02/06/2024 | Buy Now | -4.86% | Piper Sandler | Rob Owens | $40 → $45 | Maintains | Neutral | Get Alert |
| 02/06/2024 | Buy Now | 37.42% | Wedbush | Daniel Ives | $35 → $65 | Upgrade | Neutral → Outperform | Get Alert |
| 02/05/2024 | Buy Now | 33.19% | JMP Securities | Erik Suppiger | → $63 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/29/2024 | Buy Now | -11.21% | Wells Fargo | Andrew Nowinski | $29 → $42 | Maintains | Equal-Weight | Get Alert |
| 01/18/2024 | Buy Now | -4.86% | DA Davidson | Rishi Jaluria | $37 → $45 | Downgrade | Buy → Neutral | Get Alert |
| 01/10/2024 | Buy Now | -4.86% | Citigroup | Fatima Boolani | $35 → $45 | Maintains | Neutral | Get Alert |
| 12/11/2023 | Buy Now | 3.59% | JP Morgan | Brian Essex | $36 → $49 | Maintains | Neutral | Get Alert |
| 12/04/2023 | Buy Now | 9.94% | RBC Capital | Matthew Hedberg | $40 → $52 | Maintains | Outperform | Get Alert |
| 11/14/2023 | Buy Now | -4.86% | Morgan Stanley | Hamza Fodderwala | $42 → $45 | Maintains | Overweight | Get Alert |
| 11/07/2023 | Buy Now | -11.21% | Morgan Stanley | Hamza Fodderwala | $39 → $42 | Maintains | Overweight | Get Alert |
| 10/31/2023 | Buy Now | -23.89% | JP Morgan | Brian Essex | $35 → $36 | Maintains | Neutral | Get Alert |
| 10/31/2023 | Buy Now | -15.43% | Stephens & Co. | Brian Colley | $37 → $40 | Maintains | Overweight | Get Alert |
| 10/31/2023 | Buy Now | -26% | Wedbush | Daniel Ives | $32 → $35 | Maintains | Neutral | Get Alert |
| 10/27/2023 | Buy Now | -26% | JP Morgan | Brian Essex | $27 → $35 | Upgrade | Underweight → Neutral | Get Alert |
| 10/16/2023 | Buy Now | -17.55% | Morgan Stanley | Hamza Fodderwala | $34 → $39 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/13/2023 | Buy Now | -21.78% | Barclays | Saket Kalia | $35 → $37 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/30/2023 | Buy Now | -32.35% | Citigroup | Fatima Boolani | $27 → $32 | Maintains | Neutral | Get Alert |
| 08/02/2023 | Buy Now | 33.19% | JMP Securities | Erik Suppiger | → $63 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/01/2023 | Buy Now | -26% | DA Davidson | Rishi Jaluria | $30 → $35 | Maintains | Buy | Get Alert |
| 08/01/2023 | Buy Now | -28.12% | Morgan Stanley | Hamza Fodderwala | $24 → $34 | Maintains | Equal-Weight | Get Alert |
| 08/01/2023 | Buy Now | -32.35% | Stephens & Co. | Brian Colley | → $32 | Reiterates | Overweight → Overweight | Get Alert |
| 08/01/2023 | Buy Now | -32.35% | Wedbush | Daniel Ives | $28 → $32 | Maintains | Neutral | Get Alert |
| 08/01/2023 | Buy Now | -21.78% | TD Cowen | Shaul Eyal | $35 → $37 | Maintains | Outperform | Get Alert |
| 08/01/2023 | Buy Now | -36.58% | Piper Sandler | Rob Owens | $25 → $30 | Maintains | Neutral | Get Alert |
| 08/01/2023 | Buy Now | -26% | RBC Capital | Matthew Hedberg | $30 → $35 | Maintains | Outperform | Get Alert |
| 08/01/2023 | Buy Now | -32.35% | Baird | Shrenik Kothari | $30 → $32 | Maintains | Neutral | Get Alert |
| 08/01/2023 | Buy Now | -38.69% | Wells Fargo | Andrew Nowinski | $26 → $29 | Maintains | Equal-Weight | Get Alert |
| 08/01/2023 | Buy Now | -26% | Craig-Hallum | Chad Bennett | → $35 | Upgrade | Hold → Buy | Get Alert |
| 08/01/2023 | Buy Now | -26% | Barclays | Saket Kalia | $30 → $35 | Maintains | Equal-Weight | Get Alert |
| 07/31/2023 | Buy Now | -45.03% | Morgan Stanley | Hamza Fodderwala | $24 → $26 | Maintains | Equal-Weight | Get Alert |
| 05/18/2023 | Buy Now | -36.58% | DA Davidson | Rishi Jaluria | → $30 | Initiates | → Buy | Get Alert |
| 05/03/2023 | Buy Now | 33.19% | JMP Securities | Erik Suppiger | → $63 | Reiterates | → Market Outperform | Get Alert |
| 05/02/2023 | Buy Now | -36.58% | RBC Capital | Matthew Hedberg | $28 → $30 | Maintains | Outperform | Get Alert |
| 05/02/2023 | Buy Now | -32.35% | Stephens & Co. | Brian Colley | → $32 | Reiterates | → Overweight | Get Alert |
| 04/21/2023 | Buy Now | -32.35% | Stephens & Co. | Brian Colley | → $32 | Initiates | → Overweight | Get Alert |
| 03/15/2023 | Buy Now | -34.46% | RBC Capital | Matthew Hedberg | → $31 | Reiterates | → Outperform | Get Alert |
| 03/15/2023 | Buy Now | 33.19% | JMP Securities | Erik Suppiger | → $63 | Reiterates | → Market Outperform | Get Alert |
| 03/15/2023 | Buy Now | -36.58% | Barclays | Saket Kalia | $29 → $30 | Maintains | Equal-Weight | Get Alert |
| 03/15/2023 | Buy Now | -45.03% | Wells Fargo | Andrew Nowinski | → $26 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 02/08/2023 | Buy Now | -42.92% | Citigroup | Fatima Boolani | $25 → $27 | Maintains | Neutral | Get Alert |
| 02/07/2023 | Buy Now | -49.26% | Morgan Stanley | Hamza Fodderwala | $22 → $24 | Maintains | Equal-Weight | Get Alert |
| 02/07/2023 | Buy Now | -45.03% | Wells Fargo | Andrew Nowinski | $24 → $26 | Maintains | Underweight | Get Alert |
| 02/07/2023 | Buy Now | 33.19% | JMP Securities | Erik Suppiger | → $63 | Reiterates | → Market Outperform | Get Alert |
| 02/07/2023 | Buy Now | -47.15% | Piper Sandler | Rob Owens | $23 → $25 | Maintains | Neutral | Get Alert |
| 02/02/2023 | Buy Now | — | Needham | Alex Henderson | — | Downgrade | Buy → Hold | Get Alert |
| 01/30/2023 | Buy Now | -36.58% | Baird | Shrenik Kothari | → $30 | Downgrade | Outperform → Neutral | Get Alert |
| 01/24/2023 | Buy Now | -47.15% | JP Morgan | Brian Essex | → $25 | Initiates | → Underweight | Get Alert |
| 01/11/2023 | Buy Now | -45.03% | Barclays | Saket Kalia | $22 → $26 | Maintains | Equal-Weight | Get Alert |
| 01/05/2023 | Buy Now | -45.03% | Jefferies | Joseph Gallo | $30 → $26 | Downgrade | Buy → Hold | Get Alert |
| 01/05/2023 | Buy Now | -51.37% | Piper Sandler | Rob Owens | $20 → $23 | Maintains | Neutral | Get Alert |
| 11/01/2022 | Buy Now | -55.6% | Citigroup | Fatima Boolani | → $21 | Downgrade | Buy → Neutral | Get Alert |
| 11/01/2022 | Buy Now | -53.49% | Craig-Hallum | Chad Bennett | $35 → $22 | Downgrade | Buy → Hold | Get Alert |
| 11/01/2022 | Buy Now | -15.43% | Truist Securities | Joel Fishbein | $50 → $40 | Maintains | Buy | Get Alert |
| 11/01/2022 | Buy Now | -26% | Cowen & Co. | Shaul Eyal | $53 → $35 | Maintains | Outperform | Get Alert |
| 11/01/2022 | Buy Now | -38.69% | RBC Capital | Matthew Hedberg | $35 → $29 | Maintains | Outperform | Get Alert |
| 11/01/2022 | Buy Now | -53.49% | Morgan Stanley | Hamza Fodderwala | $32 → $22 | Maintains | Equal-Weight | Get Alert |
| 11/01/2022 | Buy Now | 33.19% | JMP Securities | Erik Suppiger | $73 → $63 | Maintains | Market Outperform | Get Alert |
| 11/01/2022 | Buy Now | -57.72% | Wedbush | Daniel Ives | $40 → $20 | Downgrade | Outperform → Neutral | Get Alert |
| 11/01/2022 | Buy Now | -45.03% | Needham | Alex Henderson | $32 → $26 | Maintains | Buy | Get Alert |
| 11/01/2022 | Buy Now | -53.49% | Barclays | Saket Kalia | $32 → $22 | Maintains | Equal-Weight | Get Alert |
| 11/01/2022 | Buy Now | -36.58% | Jefferies | Joseph Gallo | $35 → $30 | Maintains | Buy | Get Alert |
| 11/01/2022 | Buy Now | -49.26% | Wells Fargo | Andrew Nowinski | $35 → $24 | Downgrade | Overweight → Underweight | Get Alert |
| 11/01/2022 | Buy Now | -57.72% | Piper Sandler | Rob Owens | $37 → $20 | Downgrade | Overweight → Neutral | Get Alert |
| 10/25/2022 | Buy Now | -26% | Jefferies | Joseph Gallo | $40 → $35 | Maintains | Buy | Get Alert |
| 10/19/2022 | Buy Now | -19.66% | Baird | Shrenik Kothari | → $38 | Assumes | → Outperform | Get Alert |
| 08/02/2022 | Buy Now | -26% | Craig-Hallum | Chad Bennett | $64 → $35 | Maintains | Buy | Get Alert |
| 08/02/2022 | Buy Now | -32.35% | Morgan Stanley | Hamza Fodderwala | $35 → $32 | Maintains | Equal-Weight | Get Alert |
| 08/02/2022 | Buy Now | -2.75% | UBS | Roger Boyd | $51 → $46 | Maintains | Buy | Get Alert |
| 08/02/2022 | Buy Now | -26% | Wells Fargo | Andrew Nowinski | $40 → $35 | Maintains | Overweight | Get Alert |
| 08/02/2022 | Buy Now | -32.35% | Barclays | Saket Kalia | $36 → $32 | Maintains | Equal-Weight | Get Alert |
| 08/02/2022 | Buy Now | -21.78% | Piper Sandler | Rob Owens | $45 → $37 | Maintains | Overweight | Get Alert |
| 08/02/2022 | Buy Now | -26% | Needham | Alex Henderson | $75 → $35 | Maintains | Buy | Get Alert |
| 08/01/2022 | Buy Now | -26% | RBC Capital | Matthew Hedberg | $55 → $35 | Maintains | Outperform | Get Alert |
| 07/25/2022 | Buy Now | — | Wolfe Research | Joshua Tilton | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 07/18/2022 | Buy Now | -15.43% | Wells Fargo | Andrew Nowinski | $60 → $40 | Maintains | Overweight | Get Alert |
| 07/12/2022 | Buy Now | -23.89% | Barclays | Saket Kalia | $46 → $36 | Maintains | Equal-Weight | Get Alert |
| 06/27/2022 | Buy Now | -26% | Morgan Stanley | Hamza Fodderwala | → $35 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/23/2022 | Buy Now | -15.43% | Jefferies | Joseph Gallo | $65 → $40 | Maintains | Buy | Get Alert |
| 05/03/2022 | Buy Now | 9.94% | Wedbush | Daniel Ives | $60 → $52 | Maintains | Outperform | Get Alert |
| 05/03/2022 | Buy Now | 5.71% | Morgan Stanley | Hamza Fodderwala | $54 → $50 | Maintains | Overweight | Get Alert |
| 05/03/2022 | Buy Now | -2.75% | Barclays | Saket Kalia | $51 → $46 | Maintains | Equal-Weight | Get Alert |
| 04/29/2022 | Buy Now | 26.85% | Wells Fargo | Andrew Nowinski | → $60 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/25/2022 | Buy Now | -2.75% | Wells Fargo | Andrew Nowinski | $42 → $46 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | Buy Now | 7.82% | Barclays | Saket Kalia | $47 → $51 | Maintains | Equal-Weight | Get Alert |
| 02/08/2022 | Buy Now | 26.85% | Wedbush | Daniel Ives | $80 → $60 | Maintains | Outperform | Get Alert |
| 02/08/2022 | Buy Now | 16.28% | UBS | Fatima Boolani | $74 → $55 | Maintains | Buy | Get Alert |
| 10/25/2021 | Buy Now | 73.36% | RBC Capital | Matthew Hedberg | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Varonis Systems (VRNS) stock?
The latest price target for Varonis Systems (NASDAQ:VRNS) was reported by Barclays on July 11, 2024. The analyst firm set a price target for $55.00 expecting VRNS to rise to within 12 months (a possible 16.28% upside). 43 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Varonis Systems (VRNS)?
The latest analyst rating for Varonis Systems (NASDAQ:VRNS) was provided by Barclays, and Varonis Systems maintained their overweight rating.
When was the last upgrade for Varonis Systems (VRNS)?
The last upgrade for Varonis Systems Inc happened on June 14, 2024 when JP Morgan raised their price target to $54. JP Morgan previously had a neutral for Varonis Systems Inc.
When was the last downgrade for Varonis Systems (VRNS)?
The last downgrade for Varonis Systems Inc happened on January 18, 2024 when DA Davidson changed their price target from $37 to $45 for Varonis Systems Inc.
When is the next analyst rating going to be posted or updated for Varonis Systems (VRNS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Varonis Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Varonis Systems was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.
Is the Analyst Rating Varonis Systems (VRNS) correct?
While ratings are subjective and will change, the latest Varonis Systems (VRNS) rating was a maintained with a price target of $53.00 to $55.00. The current price Varonis Systems (VRNS) is trading at is $47.30, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.